Andang, Kent .

HRN: 28-80-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
CEFOTAXIME 500MG (VIAL)
04/09/2026
04/16/2026
IV
125mg
Q12
T/late Onset Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: